rucaparib,abiraterone,enzalutamide
pfizer,astellas,clovis oncology
['prostate', 'brca', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'triton3']
with results from the triton3 trial makes one thing clear: we need to look for brca mutations early (before metastatic crpc status). #gu23 #prostatecancer #ascogu2023
Hemato-oncologue. papa x 2 Chu-de-Quebec -Quebec City, directeur programme onco ULaval. Intérêts: gyne-onc, uro-onc, phase I.